A |
2025-01-03 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
8800.0000 |
8800.0000 |
3 |
0001070081 |
Stock Option (Right to Buy) |
A |
2025-01-03 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
4000.0000 |
16850.0000 |
1 |
0001070081 |
Common Stock |
A |
2024-06-13 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
23944.0000 |
23944.0000 |
1 |
0001281895 |
Stock Option (Right to Buy) |
D |
2024-05-08 |
|
PTC THERAPEUTICS, INC. |
4 |
G-Gift |
--D |
1650.0000 |
12850.0000 |
1 |
0001070081 |
Common Stock |
D |
2024-05-02 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
G-Gift |
--I |
59716.0000 |
113124.0000 |
2 |
0001281895 |
Common Stock |
D |
2024-05-02 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
G-Gift |
--D |
113124.0000 |
1660.0000 |
1 |
0001281895 |
Common Stock |
D |
2024-04-15 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
29624.0000 |
0.0000 |
7 |
0001281895 |
Stock Option (Right to Buy) |
D |
2024-04-15 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
10000.0000 |
114784.0000 |
5 |
0001281895 |
Common Stock |
A |
2024-04-15 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
29624.0000 |
124784.0000 |
4 |
0001281895 |
Common Stock |
D |
2024-04-12 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
70000.0000 |
29624.0000 |
6 |
0001281895 |
Stock Option (Right to Buy) |
D |
2024-04-12 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
10284.0000 |
95160.0000 |
3 |
0001281895 |
Common Stock |
D |
2024-04-12 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
59716.0000 |
105444.0000 |
2 |
0001281895 |
Common Stock |
A |
2024-04-12 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
70000.0000 |
165160.0000 |
1 |
0001281895 |
Common Stock |
A |
2024-02-15 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
10000.0000 |
10000.0000 |
2 |
0001070081 |
Stock Option (Right to Buy) |
A |
2024-02-15 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
4000.0000 |
14500.0000 |
1 |
0001070081 |
Common Stock |
A |
2023-06-22 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
25850.0000 |
25850.0000 |
1 |
0001281895 |
Stock Option (Right to Buy) |
D |
2023-04-17 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
11429.0000 |
0.0000 |
4 |
0001070081 |
Stock Option (Right to Buy) |
D |
2023-04-17 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
5188.0000 |
10500.0000 |
3 |
0001070081 |
Common Stock |
D |
2023-04-17 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
6241.0000 |
15688.0000 |
2 |
0001070081 |
Common Stock |
A |
2023-04-17 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
11429.0000 |
21929.0000 |
1 |
0001070081 |
Common Stock |
D |
2023-03-31 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
2571.0000 |
11429.0000 |
3 |
0001070081 |
Stock Option (Right to Buy) |
D |
2023-03-31 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
2571.0000 |
10500.0000 |
2 |
0001070081 |
Common Stock |
A |
2023-03-31 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
2571.0000 |
13071.0000 |
1 |
0001070081 |
Common Stock |
D |
2023-03-27 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
10000.0000 |
0.0000 |
5 |
0001070081 |
Stock Option (Right to Buy) |
D |
2023-03-27 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
100.0000 |
10500.0000 |
4 |
0001070081 |
Common Stock |
D |
2023-03-27 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
5301.0000 |
10600.0000 |
3 |
0001070081 |
Common Stock |
D |
2023-03-27 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
4599.0000 |
15901.0000 |
2 |
0001070081 |
Common Stock |
A |
2023-03-27 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
10000.0000 |
20500.0000 |
1 |
0001070081 |
Common Stock |
A |
2023-02-02 |
|
TScan Therapeutics, Inc. |
4 |
A-Award |
--D |
100000.0000 |
100000.0000 |
1 |
0001783328 |
Stock Option (Right to Buy) |
A |
2023-01-05 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
10000.0000 |
10000.0000 |
2 |
0001070081 |
Stock Option (Right to Buy) |
A |
2023-01-05 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
4000.0000 |
10500.0000 |
1 |
0001070081 |
Common Stock |
A |
2022-07-25 |
|
TScan Therapeutics, Inc. |
4 |
A-Award |
--D |
100000.0000 |
100000.0000 |
1 |
0001783328 |
Stock Option (Right to Buy) |
A |
2022-06-13 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
47745.0000 |
47745.0000 |
1 |
0001281895 |
Stock Option (Right to Buy) |
A |
2022-05-18 |
|
TScan Therapeutics, Inc. |
4 |
P-Purchase |
--D |
10000.0000 |
171569.0000 |
2 |
0001783328 |
Voting Common Stock |
A |
2022-05-18 |
|
TScan Therapeutics, Inc. |
4 |
P-Purchase |
--D |
15000.0000 |
161569.0000 |
1 |
0001783328 |
Voting Common Stock |
A |
2022-01-18 |
|
TScan Therapeutics, Inc. |
4 |
A-Award |
--D |
275000.0000 |
275000.0000 |
1 |
0001783328 |
Stock Option (Right to Buy) |
A |
2022-01-07 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
12000.0000 |
12000.0000 |
2 |
0001070081 |
Stock Option (Right To Buy) |
A |
2022-01-07 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
3200.0000 |
6500.0000 |
1 |
0001070081 |
Common Stock |
D |
2021-12-23 |
|
TScan Therapeutics, Inc. |
4 |
M-Exempt |
--D |
48670.0000 |
21161.0000 |
2 |
0001783328 |
Stock Option (Right to Buy) |
A |
2021-12-23 |
|
TScan Therapeutics, Inc. |
4 |
M-Exempt |
--D |
48670.0000 |
146569.0000 |
1 |
0001783328 |
Voting Common Stock |
A |
2021-09-08 |
|
TScan Therapeutics, Inc. |
4 |
P-Purchase |
--D |
11000.0000 |
97899.0000 |
1 |
0001783328 |
Voting Common Stock |
A |
2021-06-14 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
12236.0000 |
12236.0000 |
1 |
0001281895 |
Stock Option (Right to Buy) |
A |
2021-01-06 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
10000.0000 |
10000.0000 |
2 |
0001070081 |
Stock Option (Right To Buy) |
A |
2021-01-06 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
1650.0000 |
3300.0000 |
1 |
0001070081 |
Common Stock |
D |
2020-10-16 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
14300.0000 |
2350.0000 |
2 |
0001070081 |
Common Stock |
A |
2020-10-16 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
15000.0000 |
16650.0000 |
1 |
0001070081 |
Common Stock |
D |
2020-10-16 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
700.0000 |
1650.0000 |
3 |
0001070081 |
Common Stock |
A |
2020-10-16 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
12000.0000 |
13650.0000 |
4 |
0001070081 |
Common Stock |
D |
2020-10-16 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
500.0000 |
1650.0000 |
6 |
0001070081 |
Common Stock |
D |
2020-10-16 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
15000.0000 |
0.0000 |
7 |
0001070081 |
Stock Option (Right to Buy) |
D |
2020-10-16 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
12000.0000 |
0.0000 |
8 |
0001070081 |
Stock Option (Right to Buy) |
D |
2020-10-16 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
11500.0000 |
2150.0000 |
5 |
0001070081 |
Common Stock |
A |
2020-06-16 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
20000.0000 |
20000.0000 |
1 |
0001281895 |
Stock Option (Right to Buy) |
A |
2020-01-29 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
10000.0000 |
10000.0000 |
2 |
0001070081 |
Stock Option (Right To Buy) |
A |
2020-01-29 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
1650.0000 |
1650.0000 |
1 |
0001070081 |
Common Stock |
A |
2019-01-28 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
30000.0000 |
30000.0000 |
1 |
0001281895 |
Stock Option (Right to Buy) |
A |
2019-01-22 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
14000.0000 |
14000.0000 |
1 |
0001070081 |
Stock Option (Right to Buy) |
D |
2018-12-13 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
38768.0000 |
95160.0000 |
1 |
0001281895 |
Common Stock |
D |
2018-12-07 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
4923.0000 |
133928.0000 |
3 |
0001281895 |
Common Stock |
D |
2018-12-06 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
52809.0000 |
138851.0000 |
2 |
0001281895 |
Common Stock |
D |
2018-11-28 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
65625.0000 |
0.0000 |
4 |
0001281895 |
Restricted Stock Units |
A |
2018-11-28 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
153125.0000 |
191660.0000 |
1 |
0001281895 |
Common Stock |
A |
2018-06-05 |
|
Spero Therapeutics, Inc. |
4 |
A-Award |
--D |
6073.0000 |
6073.0000 |
1 |
0001701108 |
Stock Option (right to buy) |
A |
2018-04-02 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
21875.0000 |
65625.0000 |
3 |
0001281895 |
Restricted Stock Units |
A |
2018-04-02 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
21875.0000 |
38535.0000 |
1 |
0001281895 |
Common Stock |
A |
2018-03-30 |
|
Spero Therapeutics, Inc. |
4 |
A-Award |
--D |
12146.0000 |
12146.0000 |
1 |
0001701108 |
Stock Option (right to buy) |
A |
2018-03-29 |
|
ROCKET PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
40000.0000 |
40000.0000 |
2 |
0001281895 |
Stock Option (Right to Buy) |
A |
2018-01-03 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
14000.0000 |
14000.0000 |
1 |
0001070081 |
Stock Option (Right To Buy) |
A |
2017-01-23 |
|
INOTEK PHARMACEUTICALS CORP |
4 |
A-Award |
--D |
350000.0000 |
350000.0000 |
2 |
0001281895 |
Restricted Stock Units |
A |
2017-01-23 |
|
INOTEK PHARMACEUTICALS CORP |
4 |
A-Award |
--D |
350000.0000 |
350000.0000 |
1 |
0001281895 |
Restricted Stock Units |
A |
2017-01-06 |
|
INOTEK PHARMACEUTICALS CORP |
4 |
P-Purchase |
--D |
60000.0000 |
62765.0000 |
1 |
0001281895 |
Common Stock |
A |
2017-01-03 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
12000.0000 |
12000.0000 |
1 |
0001070081 |
Stock Option (Right To Buy) |
A |
2016-03-22 |
|
INOTEK PHARMACEUTICALS CORP |
4 |
A-Award |
--D |
215000.0000 |
215000.0000 |
1 |
0001281895 |
Stock Options (Right to Buy) |
A |
2016-01-04 |
|
PTC THERAPEUTICS, INC. |
4 |
A-Award |
--D |
12000.0000 |
12000.0000 |
1 |
0001070081 |
Stock Option (right to buy) |
D |
2015-07-06 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
15000.0000 |
15000.0000 |
4 |
0001070081 |
Stock Option (right to buy) |
A |
2015-07-06 |
|
PTC THERAPEUTICS, INC. |
4 |
M-Exempt |
--D |
15000.0000 |
23604.0000 |
1 |
0001070081 |
Common Stock |
D |
2015-07-06 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
22904.0000 |
700.0000 |
2 |
0001070081 |
Common Stock |
D |
2015-07-06 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
700.0000 |
0.0000 |
3 |
0001070081 |
Common Stock |
A |
2015-06-24 |
|
INOTEK PHARMACEUTICALS CORP |
4 |
A-Award |
--D |
150000.0000 |
548497.0000 |
1 |
0001281895 |
Stock Options (Right to Buy) |
D |
2015-03-23 |
|
PTC THERAPEUTICS, INC. |
4 |
S-Sale |
--D |
117.0000 |
8604.0000 |
2 |
0001070081 |
Common Stock |